| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT00325637 | Hypertension|Stroke | Drug: cilnidipine | Boryung Pharmaceutical Co., Ltd | Phase 3 | 2005-01-01 | 2008-12-11 |
| NCT00325936 | Hypertension|Metabolic Syndrome X | Drug: Cilnidipine | Boryung Pharmaceutical Co., Ltd | Phase 4 | 2005-07-01 | 2008-08-26 |
| NCT02343250 | Hypertension | Drug: Cilnidipine/Valsartan|Drug: Cilnidipine+Valsartan|Drug: Cilnidipine/Valsartan|Drug: Cilnidipine+Valsartan | IlDong Pharmaceutical Co Ltd | Phase 1 | 2015-03-01 | 2016-01-11 |
| NCT02088008 | Healthy Volunteers | Drug: cinidipine, valsartan | IlDong Pharmaceutical Co Ltd | Phase 1 | 2014-05-01 | 2014-03-12 |
| NCT01838967 | Healthy | Drug: C - V - C+V|Drug: C - C+V - V|Drug: V - C - C+V|Drug: V - C+V - C|Drug: C+V - C - V|Drug: C+V - V - C | IlDong Pharmaceutical Co Ltd | Phase 1 | 2013-04-01 | 2013-10-11 |
| NCT02145104 | Hypertension | Drug: valsartan 160mg, cilnidipine 10mg, cilinidipine 5mg | IlDong Pharmaceutical Co Ltd | Phase 3 | 2014-05-01 | 2014-05-20 |
| NCT00890279 | Kidney, Polycystic, Autosomal Dominant | Drug: Cilnidipine|Drug: Imidapril | Ministry of Health, Labour and Welfare, Japan | Phase 2 | 2009-07-01 | 2009-12-01 |
| NCT00541853 | Kidney, Polycystic, Autosomal Dominant | Drug: Candesartan|Drug: Candesartan and Cilnidipine|Drug: Candesartan plus non-CCB agents | Kyorin University|Ministry of Health, Labour and Welfare, Japan | Phase 4 | 2007-12-01 | 2007-10-17 |
